On July 22, 2026, the United States House of Representatives passed H.R. 7008, the Stop Insider Trading Act, by a vote of 232 to 198. The bill would prohibit Members of Congress, their spouses, and dependent children from purchasing individual securities issued by publicly traded companies. It would also require advance public notice of intended sales of existing holdings and impose financial penalties for violations, including forfeiture of net gains.

The measure reflects continued public concern over lawmakers trading while possessing access to non-public information by virtue of office. At the same time, the bill is notably limited. It does not require divestment of existing stock holdings, does not prohibit sales themselves, and does not extend to the President, Vice President, or other executive-branch officials. Combined with unrelated voter-identification provisions, its future in the Senate remains uncertain.

Whatever becomes of the bill, it sharpens a practical question that many investors have already begun to ask: if elected officials have long enjoyed informational advantages, and if their trades eventually become public through disclosure rules, may ordinary investors ethically profit by following those same signals?

A growing segment of the investing public has answered yes. Newsletters, social-media accounts, and subscription services now market the practice of monitoring congressional stock disclosures and replicating the trades. The reasoning is simple: if public officials appear to trade with superior timing or insight, outside investors may as well capture whatever part of that advantage becomes visible. In that way of thinking, once a trade is publicly disclosed, the ethical problem has ended, and only the market opportunity remains.

Torah ethics reject that conclusion.

To begin with, where civil law prohibits insider trading, the prohibition carries force under the principle of dina d’malkhuta dina, the law of the land is law. But even if secular law were incomplete, inconsistently enforced, or narrowed in scope, the moral problem would not disappear. Torah commercial ethics are not exhausted by whatever the civil statute happens to forbid at a given moment.

At the center of the issue is the misuse of information held in trust. Information acquired by virtue of a position – whether in corporate office or public office – is not a private asset to be converted into personal trading gain. It belongs, in a meaningful ethical sense, to the institution and purpose for which it was entrusted. Using such information for personal benefit is therefore not merely an aggressive trading strategy. It is a breach of the trust under which the information was obtained.

Closely related is the prohibition of geneivat da’at: creating or exploiting a materially misleading impression in the course of dealing with others. A market transaction may be anonymous, but anonymity does not remove the moral significance of informational asymmetry. When one party acts on material knowledge unavailable to the other side, and that concealed knowledge determines the trade, the fairness of the transaction is compromised. The fact that securities markets operate through impersonal exchanges does not eliminate the ethical problem; it can instead obscure it.

That addresses the conduct of the insider himself. The harder question is whether an outside observer may profit by following trades that are known or strongly believed to have been based on such misuse of information.

Here too the answer should be no. The fact that the trade later becomes visible does not cleanse the character of the advantage that produced it. If an observer buys or sells because he believes the original actor traded on an improper informational benefit, then he is not responding merely to neutral market data. He is deliberately attempting to benefit from the fruits of another person’s breach of trust.

That distinction matters. Public disclosure does not transform wrongful advantage into ethically neutral opportunity. Visibility may change the legal status of the information for some purposes, but it does not erase the moral problem of knowingly attaching oneself to gain produced by misconduct.

The point can be stated simply. One may not justify participation in a wrongful advantage merely because one encountered its effects after they entered public view. The proper response to misuse of entrusted information is accountability, not imitation.

This is why the popular defense of congressional-trade copying is ethically inadequate. It says, in effect, that once the original act cannot be undone, others are free to share in its benefits. Torah ethics point in the opposite direction. The persistence of a wrong is not permission to join it at a later stage. Nor does public frustration with selective enforcement create a license for private participation.

The House’s passage of the Stop Insider Trading Act is therefore significant, but only up to a point. It acknowledges that lawmakers should not be permitted to use public office as a platform for private trading advantage. Yet the deeper issue is not only legislative design. It is the moral instinct of the broader public. When people suspect that officeholders are profiting from privileged access, the healthiest response is to demand higher standards of accountability – not to ask how to mirror the same conduct more efficiently.

For that reason, investors tempted to “jump in” should resist the impulse. Even where disclosure rules make trades observable, and even where civil law may leave gaps, Torah principles of honesty, fairness, and fiduciary responsibility still apply. Ill-gotten advantage does not become ethically fit for use simply because it has become visible. Personal integrity in commerce requires more than refraining from the initial breach. It also requires refusing to profit from the breach of others.